Open Orphan secures £3m Covid-19 challenge study contract
Pharmaceutical services company Open Orphan had signed contract worth £3 million with Imperial College London to manufacture a SARS-CoV-2 challenge virus.
Challenge studies involve intentionally...
Mon, 10/05/2021 - 07:36